Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Renal Insufficiency

• Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants
• Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease
• PK/PD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
• Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
• Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
• CAR-T Cell Therapy for Desensitization in Kidney Transplantation
• A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function
• A Study of TAK-279 in Adults With or Without Kidney Problems
• Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
• A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
• RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
• A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
• A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function
• A Study of LY3502970 in Participants With Normal and Impaired Renal Function
• CAR T-cell Therapy in Patients With Renal Dysfunction
• Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit
• Delayed Tolerance Through Mixed Chimerism
• A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
• Study of GBT021601 in Participants With Renal Impairment
• A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218
• A Study of LY3819469 in Participants With Impaired and Normal Renal Function
• A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010
• Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
• Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
• A Study of LY3473329 in Participants With Impaired and Normal Renal Function
• Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
• Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
• A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function
• SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency
• Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function
• Hepatic Impairment and Renal Impairment Study of SIM0417 Combined With Ritonavir
• The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
• A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems
• A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Kidney Problems
• Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function
• Evaluation of the Pharmacokinetics and Safety of VX 548 in Participants With Severe Renal Impairment
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
• Empagliflozin in ESKD - A Feasibility Study
• A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment
• A Study of MK-2060 in Participants With Chronic Kidney Disease (MK-2060-011)
• Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose
• Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
• A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
• Study of AT-527 in Subjects With Normal and Impaired Renal Function
• Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
• A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
• A Study to Learn How the Study Treatment BAY1753011 Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body When Given Once as Tablet in Male and Female Participants With Reduced Kidney Function Compared to
• Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation
• Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
• Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment
• Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants
• Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
• A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal
• Study of SHR6390 in Renal Insufficiency and Healthy Subjects
• A Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics of PF-07081532
• An Open-label Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment
• A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well
• A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment
• A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function
• Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543
• PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care
• PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers
• A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
• Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics, Safety and Tolerability of GC4419
• A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Ki
• To Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal Function
• A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003)
• The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD
• Efficacy and Safety of Metformin Versus Empagliflozin on Chronic Kidney Disease Progression
• Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
• A Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of S-217622 in Participants With Renal Impairment and Healthy Participants
• A Pharmacokinetic Study of Polymyxin B in Healthy Subjects and Subjects With Renal Insufficiency
• MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
• Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
• DAPAgliflozin for Renal Protection in Heart Transplant Recipients
• A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
• A Trial of HR17031 Injection With Renal Insufficiency
• Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
• A Phase 1 of Epetraborole Tablets
• Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.
• Extended-Release Tacrolimus Following Liver Transplantation
• Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
• Spironolactone in CKD Enabled by Chlorthalidone: PILOT
• Fruquintinib Renal Impairment Study
• Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
• a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects
• A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment
• A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment
• Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients
• SGLT2 Inhibition in Hemodialysis
• A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment
• Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
• A Study of ASP0367 in People With Kidneys That do Not Work Well and in Healthy People
• A Study to Assess Zibotentan Pharmacokinetics in Participants With Moderate Hepatic and Moderate Renal Impairment
• Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function
• Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis
• Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment
• Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
• A Study of MK-0616 in Participants With Moderate Renal Impairment (MK-0616-007)
• A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function
• A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
• Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function
• Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (Factor XI Hemodialysis Study) (MK-2060-007)
• Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
• A Study to Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects
• The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics
• A Study of Belzutifan (MK-6482) in Participants With Renal Impairment (MK-6482-021)
• Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital
• A Study of JNJ-73763989 in Adult Participants With Renal Impairment
• A Study to Assess the Pharmacokinetics (Uptake of Drugs by the Body), Safety and Tolerability of AZD4831 in Participants With Severe Renal Impairment and Healthy Volunteers
• A Feasibility Study of Octreotide Infusion During Liver Transplant.
• Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction
• Study to Evaluate Safety and Tolerability of Iberdomide (CC-220) in Participants With Kidney Impairment Compared to Participants With Normal Kidney Function
• Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC)
• Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants
• Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.
• Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil
• A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects
• Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function
• A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment
• To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Renal Function and Renal Impairment.
• Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function
• Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
• Surufatinib Renal Impairment Study
• Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions
• A Study to Investigate the Effect of Severe Renal Impairment on Gilteritinib Compared to Healthy Participants With Normal Renal Function
• Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402)
• PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function
• Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
• Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
• Study of ALXN2050 in Participants With Renal Impairment
• An Open Label Phase IV Study to Evaluate Dapagliflozin Treatment in Type 2 Diabetes Mellitus Patients With Impaired Renal Function
• A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult Participants
• STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENT
• Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD
• Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
• QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir
• Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")
• Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
• Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment
• Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
• A Study to Investigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal Function
• A Study to Evaluate the Effect of Renal Impairment on JNJ-56136379 in Adult Participants
• Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk
• Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment
• Possibility to Stop Perdialytic Heparin Therapy in Hemodialysed Patients With HeprAN ™ Membrane and Treated by Long-term Anticoagulation With VKA
• Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery
• Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
• A Pharmacokinetic Study of Saroglitazar Magnesium in Subjects With Severe Renal Impairment and Normal Renal Function
• A Study to Evaluate the Effect of Renal Impairment on JNJ-64417184 and Its Two Minor Metabolites JNJ-68294291 and JNJ-65201526 in Adult Participants
• A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function
• A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
• TDF Dose Adjustment VS. Switching to TAF in TDF-experienced CHB Patients With Renal Impairment
• Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Ag
• African American Study of Kidney Disease and Hypertension
• A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
• Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction
• Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy
• HCV + to HCV - Kidney Transplant
• Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis
• Renal Impairment Study of PF-06700841
• Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
• RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects
• Pharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function
• A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 in Participants With Various Levels of Kidney Function
• A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
• Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function
• Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function
• Articaine vs Dexmedetomidine Supplemented Articaine
• A Research Study to Show Aprocitentan is Efficacious and Safe to Treat Patients With Uncontrolled Blood Pressure and Chronic Kidney Disease.
• Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
• Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics
• Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function
• A Study With Iron Sucrose in Healthy Volunteers and Chronic Kidney Disease Stage 3-4 Subjects
• Everolimus Monotherapy as Immunosuppression After Liver Transplant
• A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys
• Angiotensin 2 for Hepatorenal Syndrome
• A Renal Impairment Study for PF-06651600
• Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
• Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects
• Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
• A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variants and Severe Renal Impairment
• CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction
• Apixaban in Subjects With Peritoneal Dialysis
• Oral Iron in Children With Chronic Kidney Disease
• Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
• Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function
• Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production
• Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment
• Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial
• Desflurane vs. Sevoflurane in Endovascular Aortic Repair
• A Study to Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease
• Tobramycin Administered at the Beginning of Dialysis
• Neuromuscular Blockade in Patients With Severe Renal Impairment
• Single-Dose Study to Evaluate the PKs of Pretomanid in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
• A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease.
• Safety of Sofosbuvir in People With Advanced Kidney Failure
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
• A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
• High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
• Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients
• XIENCE 28 USA Study
• A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems
• After Surgery Acute Renal Failure Incidence in Total Knee Arthroplasty With and Without Tourniquet
• RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
• Multi-center Study to Transplant Hepatitis-C Infected Kidneys
• A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
• Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
• The Vienna Prograf and Endothelial Progenitor Cell Extension Study
• A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
• TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
• Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
• Effect of Vitamin D Supplementation on Balance in CKD
• VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment
• Effect of Venglustat in Patients With Renal Impairment
• Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
• Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal Insufficiency
• A Renal Impairment Study for PF-04965842
• Predictors of Response to Iron and Erythropoietin Stimulating Agents
• Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function
• Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
• A PK Study of Melphalan During Treatment With Melphalan Flufenamide (Melflufen) and Dex in RRMM Pat With Impaired Renal Function
• RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine
• Serum Ceftazidime Concentrations in Hemodialysis Patients
• Pharmacokinetics of Antiepileptics in Patients on CRRT
• Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
• Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
• Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant
• Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function
• Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies
• Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers
• Glasdegib Renal Impairment Study
• Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
• Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.
• A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
• Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis.
• A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated
• A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
• A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
• Maintenance Treatment of Renal Anemia in Dialysis Subjects
• Lorlatinib Renal Impairment Study
• Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients
• Safety and Efficacy of Two Year Spnol and Maximal R Blockad Therapy
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
• Sodium Chloride and Contrast Nephropathy
• Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
• Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
• Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
• Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function
• Effect of Intermittent Infusion Versus Continuous Infusion of Vancomycin on Kidney Failure in Critically Ill Patients
• Effect of Renal Impairment on Evobrutinib Pharmacokinetics (PK)
• the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD
• A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects
• Renal Impairment Study
• Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
• Influence of Albumin on Acute Renal Dysfunction Associated With Cardiac Surgery Under Extracorporeal Circulation
• XIENCE 28 Global Study
• A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects
• A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
• A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects
• A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
• Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
• Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function
• Plasma CO2 Removal Due to CRRT and Its Influence on Indirect Calorimetry
• Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
• Abdominal Wall Transplant
• Evaluation of the Pharmacokinetics, Safety, and Tolerability of Intravenous ETX2514 and Sulbactam Administered Concurrently to Subjects With Various Degrees of Renal Impairment and Healthy Matched Control Subjects
• A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 1467335 is Processed in the Body
• A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
• Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment
• Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
• Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)
• Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
• Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects
• Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects
• Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment
• Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
• A Study to Evaluate the Pharmacokinetics of Entinostat in Adult Subjects With Normal and Impaired Renal Function
• A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-64041575 in Adult Participants With Various Degrees of Renal Function
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function
• Study of Copanlisib in Hepatic or Renal Impairment
• A Study to Evaluate ACT-132577 in Healthy Subjects and in People With Severe Kidney Disease
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interaction Potential of ACHN-383 and ACHN-789
• Single-Dose PK Study of GBT440 in Subjects With Renal Impairment
• A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
• Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
• A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)
• Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
• Empagliflozin in Renal Transplant Recipients
• The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
• Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease
• Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.
• TAF for HIV-HBV With Renal Dysfunction
• The Pharmacokinetics of Gefapixant (MK-7264) in Participants With Renal Insufficiency (MK-7264-026)
• Preserve-Transplant Study
• A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment
• Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
• Pharmacokinetics and Safety of Fevipiprant in Patients With Renal Impairment Compared to Matched Healthy Subjects
• Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients
• Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir
• Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
• Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome
• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
• Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
• Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients
• Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding
• Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
• A Study to Investigate the Effect of Renal Function and Hemodialysis on the Pharmacokinetics (PK) of RO7079901
• Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
• Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
• A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
• A Study to Evaluate the Effect of Severe Renal Impairment on the Single-dose Pharmacokinetics of Odalasvir
• Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
• Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function
• Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
• Neurovascular Transduction During Exercise in Chronic Kidney Disease
• Preemptive Treatment With Grazoprevir and Elbasvir for Donor HCV Positive to Recipient HCV Negative Kidney Transplant
• To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment
• Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
• Effectiveness of Probiotics to Treat End Stage Renal Disease
• IV Antibiotics With Lavage for Severe PD Peritonitis
• A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
• HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant
• Efficacity and Safety of Metformin XR in CKD Stage 1 to 3
• A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335
• Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)
• Oral Anticoagulation in Haemodialysis Patients
• Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury
• Effects of Dexmedetomidine on Postoperative Renal Function Recovery After Kidney Transplantation in Adult Patients
• Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT)
• A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment
• Biological and Clinical Measurements Following Systemic Leakage When a Citrate or Heparin Lock is Used
• Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
• Dual Transversus Abdominis Plane Block in Pediatric Renal Transplant: Effect on Pain Control
• Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment
• Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study
• Chlorthalidone in Chronic Kidney Disease
• Pharmacokinetics Study of Nemonoxacin Malate Capsules in Subjects With Severe Impaired Renal Function
• Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
• A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency
• Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
• SP2086 Pharmacokinetic Study in Renal Insufficiency Patients
• A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects
• Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency
• Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment
• PK of Pacritinib in Patients With Mild, Moderate, Severe Renal Impairment and ESRD Compared to Healthy Subjects
• Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)
• Targeting Central Pulsatile Hemodynamics in Chronic Kidney Disease
• A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
• PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function
• Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
• The Impact of Early Protocol Biopsy in Kidney Transplant
• Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
• Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
• May Metformin be Used in Renal Failure?
• A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment
• Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment
• Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.
• A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
• To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.
• Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function
• A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)
• GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
• A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
• The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes
• Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
• Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution
• Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)
• Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
• Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
• Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
• Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer
• Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)
• A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)
• Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects
• ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis
• Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm Infants
• DS-5565 Phase III Study for Renal Impairment in Japanese Subjects
• A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
• A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
• Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment
• Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function
• Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
• Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis
• Diuretic/Cool Dialysate Trial
• Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
• A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
• The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
• Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment
• Renal Function During Pediatric Anesthesia
• Montelukast for Treatment of Uremic Pruritus
• Effects of Sevoflurane and Desflurane on Treg
• The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction
• Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation
• A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate
• Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With
• Effects of Levosimendan in Acute Kidney Injury After Cardiac Surgery
• Atorvastatin in the Recipient's Kidney Graft From a Living Donor
• Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Dis
• Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
• Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment
• Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function
• Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
• Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
• Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D
• TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Pain Management After Cardiac Surgery - Opioids or NSAID
• Optimal Administration of Allopurinol in Dialysis Patients
• Intensive Versus Standard Hemodialysis CVC Dysfunction Protocol
• Linagliptin's Effect on CD34+ Stem Cells
• A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment
• Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg)
• Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
• Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function
• Renal Osteodystrophy: An Individual Management Approach
• A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
• CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%
• Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011
• Optimising Renal Outcome in Myeloma Renal Failure
• Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)
• Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
• Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment
• Pharmacokinetics of Bictegravir in Adults With Normal and Impaired Renal Function
• A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function
• An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Diseas
• Evaluation of Gadoterate in Patients With Decreased Kidney Function
• European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
• Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
• Does Terlipressin Improve Renal Outcome After Liver Surgery
• Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
• GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant
• rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics
• Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney
• Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment
• Clinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)
• Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)
• Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'
• Pharmacokinetic Comparison Of All FK-506 Formulations
• An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting
• A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
• Vitamin K Supplementation in Patients on Hemodialysis
• Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
• To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects
• A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
• Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study
• A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics
• Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
• Temocillin Pharmacokinetic in Hemodialysis
• The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
• Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment
• Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal Impairment
• A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
• Mild, Moderate and Severe Renal Impairment Study
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease
• PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients
• Belatacept 3 Month Post Transplant Conversion Study
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
• A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function
• Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment
• Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis
• The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects
• BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis
• Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
• Long-term Effects of Intensive Insulin Treatment in Type 1 Diabetes
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
• Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
• Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Virem
• Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment
• Afatinib in Subjects With Kidney Dysfunction
• Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
• A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
• Study Of Palbociclib (PD-0332991) In Renal Impairment
• Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects
• Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients
• Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
• Long-term Pre-dialysis Extension in Europe and Asia Pacific
• Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.
• Dose-finding of Rivaroxaban in Hemodialysis
• Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
• A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.
• PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
• Caudal Epidural Catheterization in Pediatric Renal Transplant: Effect on Hemodynamics and Pain After Surgery
• The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
• Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
• Maintenance Treatment of Anemia in Pre-dialysis Subjects With Chronic Kidney Disease on Darbepoetin Treatment Versus BAY85-3934
• 15141 Fixed Dose Correction / naïve and Pre Dialysis (Europe and Asia Pacific)
• The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
• Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function
• Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)
• Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subjects
• Study to Evaluate the Pharmacokinetics of Velpatasvir in Participants With Normal Renal Function and Severe Renal Impairment
• Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites
• A Study of LY2928057 in Hemodialysis Participants
• Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
• ISCHEMIA-Chronic Kidney Disease Trial
• EVP-6124 Renal Impairment Study
• Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.
• Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
• Clinical Trial to Compare Effectiveness of Diuretics in Hemodialysis Patients With Residual Renal Function
• Comparing Everolimus and Sirolimus in Renal Transplant Recipients
• Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
• Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects
• Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
• A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)
• Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
• Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
• Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency
• Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired Patients
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
• The Effects of Dexmedetomidine on Early Stage Renal Functions in Pediatric Patients
• Efficacy and Safety of a Double Icodextrin Dose in Elderly Incident CAPD Patients on Incremental PD.
• The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)
• Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
• Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects
• Use of Tinzaparin for Anticoagulation in Hemodialysis
• A Study of LY2409021 in Participants With Different Levels of Kidney Function
• Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function
• A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
• Protocolized Diuretic Strategy in Cardiorenal Failure
• A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.
• Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment
• Acute Renal Failure Post Liver Transplantation
• Role of Turmeric on Oxidative Modulation in ESRD Patients
• A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
• Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment
• Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
• Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
• Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients
• A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
• Use Of Fragmin In Hemodialysis
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• PK of Serelaxin in Severe Renal Impairment and ESRD
• Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction
• Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children
• Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis
• Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment
• Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs
• Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
• ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
• An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction
• Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery
• EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
• Study of Romosozumab (AMG 785) Administered to Healthy Participants and Patients With Stage 4 Renal Impairment or Stage 5 Renal Impairment Requiring Hemodialysis
• BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
• The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)
• Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment
• Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
• Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects
• PF-04634817 Renal Impairment Study
• Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration
• Efficacy and Safety of Sugammadex in Renal Diseased Patients
• Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate
• An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
• Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
• Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment
• A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
• A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function
• Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
• The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis
• HaemoDYNAMICs in Primary and Secondary Hypertension
• Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
• Pharmacokinetics Of CP-690,550 In Patients With Impaired Renal Function
• Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency
• Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function
• Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function
• Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol
• Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
• Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
• Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Function
• A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.
• A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
• N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
• Qutenza for Critical Ischaemia in End Stage Renal Failure
• Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal Impairment
• Magnesium Replacement Therapy to Prevent Acute Renal Failure in Critically Ill Patients
• A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
• Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
• The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas
• Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
• A Phase 1 Study to Assess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of Ranolazine
• Prucalopride Subjects With Renal Impairment
• Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant
• Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
• The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
• Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
• Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects
• Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction
• A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Effects of Bardoxolone Methyl on Body Composition in Patients With Stage 4 Chronic Kidney Disease and Type 2 Diabetes Mellitus
• Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
• The Everolimus-Transplant Exit Strategy Trial (E-TEST)
• Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children
• Renal Transplantation in the Elderly - nEverOld Study
• A Single Dose Study of the Pharmacokinetics of Vibegron (MK-4618) in Participants With Renal Insufficiency (MK-4618-014)
• Recombinant BNP on Heart and Renal Function in Acute Heart Failure
• Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
• Pharmacokinetics of BF2.649 in Renal Impairment
• Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
• Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment
• Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
• Study of Everolimus in de Novo Renal Transplant Recipients
• Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)
• Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction
• Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure
• Fosrenol and Phosphorus Balance - Lanthanum Carbonate
• Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
• Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal Impairment
• Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
• A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers
• Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)
• Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.
• Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment
• Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function
• Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function
• Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
• A Study of MK-7145 in Participants With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II) (MK-7145-011)
• Pharmacokinetics of LCQ908 in Patients With Renal Impairment
• Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
• Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
• Pilot Assessment of the Effects of Bardoxolone Methyl on Renal Perfusion, Systemic Haemodynamics and Cardiac Function in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance
• A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
• Effect of Epinephrine on Systemic Absorption of Mepivacaine in Uremic Patients
• Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function
• A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
• Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)
• A Study on the Effect of Renal Impairment on the Pharmacokinetics of RO4917838
• Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
• Pharmacokinetics in Subjects With Renal Impairment
• Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
• Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients
• Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome
• Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia
• Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
• Fondaparinux in Critically Ill Patients With Renal Failure
• Prevention of Serious Adverse Events Following Angiography
• Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
• PK Study of ACHN-490 Injection in Renally Impaired Subjects
• Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
• Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients
• Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction
• Renal Transplantation and Raltegravir in HIV-Infected Patients
• A Pharmacokinetics and Safety Study in Subjects With Renal Impairment
• Safety and Dialysability of Dotarem® in Dialysed Patients
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
• Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients
• Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
• Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
• A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment
• Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
• An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects
• The Impact of Nebivolol Versus Metoprolol on Quality of Life
• Does Nesiritide Provide Renal Protection
• Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
• Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
• Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)
• Dexpramipexole Renal PK Study
• Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery
• Blood Pressure in Dialysis Patients
• A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
• An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function
• Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction
• A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency
• A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)
• Liraglutide Treatment to Patients With Severe Renal Insufficiency
• TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435
• Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
• Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
• Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
• Safinamide Renal Impairment Trial
• Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function
• A Phase I Clinical Trial to Evaluate the Effect of Renal Impairment on Pharmacokinetics of NOX-E36
• Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532
• Pharmacokinetics, Safety, and Tolerability of Methylnaltrexone (MNTX) in Subjects With Impaired Renal Function
• Prevention of Contrast Induced Nephropathy by Erythropoietin
• Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
• Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis
• N-acetylcysteine to Prevent Renal Failure
• A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function
• Nephrogenic Systemic Fibrosis With Gadollinum
• Exercise Intolerance in Renal Failure
• Low Molecular Weight Heparin for Hemodialysis Anticoagulation
• Dolutegravir Renal Impairment Study
• Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
• Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
• A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
• A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
• A Study to Assess the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Renal Function and Subjects With Varying Degrees of Renal Impairment
• A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
• A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment
• Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
• Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction
• Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
• De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction
• A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function
• Renal Impairment Study With ASP1941
• Low Dose Thymoglobin in Renal Transplant Patients
• A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
• Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel
• The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
• A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)
• Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
• Renal Protective Effects of Restricted Protein Dietary With α-keto Acid in CAPD Patients
• Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
• Safety Study of TRK-820 for Patient With Hemodialysis
• A Study of Fostamatinib in Subjects With Impaired Kidney Function
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis
• To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function
• An Open-label, Dose Escalation Multi-center Study in Patients With Advanced Cancer to Determine the Infusion Rate Effect of ASA 404 With Paclitaxel Plus Carboplatin Regimen or Docetaxel on the Pharmacokietics of Free and Total ASA404
• Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment
• Bosutinib In Subjects With Renal Impairment
• Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
• Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients
• Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
• Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder.
• Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
• FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease
• Hemodialysis Vitamin D Pilot
• Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
• Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
• Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy
• Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
• A Study in Participants With End-Stage Renal Disease
• Effects of HIgh Volume COntinuous REnal Replacement Therapy in Patients With Septic Acute Kidney Injury
• A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
• Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
• Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
• Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency
• Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
• Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
• A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
• Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment
• A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients
• Donor Simvastatin Treatment in Organ Transplantation
• The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
• Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers
• The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847
• Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment
• The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
• A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
• Effects of Spironolactone in Dialysis
• Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients
• Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.
• Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038)
• "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
• Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury
• Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment
• A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers
• Study of Erythropoietin (EPO) Administration Schedule
• Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment
• Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
• The Impact of Pomegranate Extract on Chronic Cardiomyopathy Complicated by Renal Insufficiency (ImPrOVE): a Pilot Study
• Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
• A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
• A Study to Assess the Pharmacokinetics, Pharmacodynamics of ASP1941 in Diabetes Mellitus Patients With Renal Impairment
• TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
• Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects
• Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
• Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)
• ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis
• Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment
• Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
• Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
• Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
• An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment
• Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
• A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• To Compare the Pharmacokinetics of Avanafil in Subjects With Mild and Moderate Renal Impairment to Subjects With Normal Renal Function.
• Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease
• Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients
• Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)
• Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers
• A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment
• Effect of Turmeric on Pruritus in Hemodialysis Patients
• Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Treatment
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
• Pharmacokinetics of 10 mg Teduglutide in Subjects With Renal Impairment Compared to Healthy Subjects With Normal Renal Function
• Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
• CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation
• Renal Impairment Associated With Colistin Levels
• A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
• Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
• The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers
• A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function
• A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment
• N-acetyl-cysteine (NAC) and Kidney Graft Function
• Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates
• Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment
• Fenoldopam in Pediatric Cardiac Surgery
• The Effects of Decreasing the Lasix Dose on the Cardiorenal System
• Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
• Furosemide in Early Acute Kidney Injury
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
• Low Dose Intravenous (IV) Infusion of BNP in the Presence and Absence of Acute Type V Phosphodiesterase (PDE V) in Improving Renal Function in Hospitalized Chronic Heart Failure (CHF) Patients With Renal Dysfunction
• Vitamin D and Chronic Renal Insufficiency
• Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
• Observational Prospective Study on Patients Treated With Norditropin®
• Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
• Prevention of Perioperative Acute Renal Failure
• Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis
• Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients
• Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)
• Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
• A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
• Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
• A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients
• Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
• VX-950-TiDP24-C132: A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Telaprevir.
• Lenalidomide and Dexamethasone for Treatment of Patients With Acute Myeloma (Light Chain)-Induced Renal Failure
• Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
• Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF)
• Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose
• Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
• Prostacyclin's Effect on Platelet Responsiveness
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
• Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
• Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment
• Pharmacokinetic Assessment of Sodium Sulfide in Subjects With Impaired Renal Function
• Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis
• Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
• N-acetylcysteine Plus Deferoxamine for Patients With Hypotension
• Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment
• Renal Impairment Study
• Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
• Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot Study
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
• Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation
• Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
• Effect of Renal Impairment on the Pharmacokinetics of NN9535
• A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)
• Safety of Gadovist in Renally Impaired Patients
• Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
• The Clinical Evaluation of the Dose of Erythropoietins Trial
• Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide
• Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction
• Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients
• Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
• Standard Vs Adjusted Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock
• Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant
• Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease
• Open-Label, Single-Dose Study to Evaluate the Safety and PK of DIC075V in Subjects With Renal Insufficiency and Hepatic Impairment Compared to Healthy Subjects and Evaluate the Safety and Pharmacokinetics of HPβCD When Administered in DIC075V Compa
• Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive
• Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
• Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
• Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan
• Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
• A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function
• Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
• A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment
• Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment
• Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
• Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
• Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
• Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
• A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment
• Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
• Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
• A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
• Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.
• A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment
• Rifaximin Versus Lactulose in Renal Failure
• 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
• Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency
• Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
• Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity
• Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
• The Acetylcysteine for Contrast-Induced Nephropathy Trial
• Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers
• Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
• Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.
• Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
• Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
• A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function.
• Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
• Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
• Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
• Safety Study of AZD5672 in Renally Impaired Subjects
• Renal Blood Flow Measurement With Positron Emission Tomography (PET)
• Angiotensin in Septic Kidney Injury Trial
• Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency
• Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study
• Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
• Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
• BK Viremia After Renal Transplantation
• A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
• Recombinant Human Erythropoietin Use in Intensive Care Unit (ICU) Patients: Does it Prevent Acute Renal Failure
• A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
• Protocol to Assess the Severity of Acute Kidney Injury
• OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis
• DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
• Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment
• Dialysis of Sugammadex in Participants With Severe Renal Impairment (Study 19.4.333) (P05773)
• Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
• Effect of Erythropoietin (EPO) in Kidney After Cardiac Surgery
• Effects of MK7418 on Diuresis and Renal Function in Congestive Heart Failure Patients
• Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
• Renal Safety Evaluation After Dotarem®-Enhanced MRI
• Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency
• Testosterone Replacement Therapy in Advanced Chronic Kidney Disease
• Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension
• Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
• Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
• Fenoldopam and Acute Renal Failure
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
• Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
• Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
• The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
• CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment
• Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function
• The Effects of Intensive Insulin on Somatic and Visceral Protein Turnover in Acute Kidney Injury (AKI)
• Oral Paricalcitol in Kidney Transplant Recipients
• Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
• An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis
• Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration
• Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants
• Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction
• Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure
• Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function
• Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
• Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
• Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients
• Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
• Fenoldopam and Ketanserin for Acute Kidney Failure Prevention After Cardiac Surgery
• Minocycline to Prevent Acute Kidney Injury After Cardiac Surgery
• Hypertonic Saline Solution in Heart Failure
• Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
• Renal Impairment in Type 2 Diabetic Subjects
• A Dose Escalation and Safety Study of I5NP in Patients Undergoing Major Cardiovascular Surgery
• Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
• Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function
• Comparison Between Effects of Two Iron Preparations on Protein in the Urine
• N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
• How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
• Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure
• Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy
• Dynepo Long-Term Safety Study
• A Study in Sepsis Patients With Renal Failure
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
• Effect of N-Acetylcysteine on Residual Renal Function in Chronic Hemodialysis Patients
• NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
• A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4
• Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
• A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.
• Fibrosis in Renal Allografts
• Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
• Use of Bicarbonate to Reduce the Incidence of Acute Renal Failure After Cardiac Surgery
• A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
• Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction
• Fall Prevention by Alfacalcidol and Training
• Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)
• Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.
• Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
• Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
• A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery
• Effects of Creatine Supplementation on Renal Function
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
• Acute Renal Failure in the Surgical Intense Care Units - NTUH-SICU-ARF (NSARF) Study
• Dynepo Infrequent Dosing Study
• The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment
• Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
• Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
• Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
• Inhibition of Aldosterone in Patients With Chronic Renal Disease
• Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine
• Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
• A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
• Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
• Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly
• Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome
• Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
• Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
• Evaluating Patients With Varying Degrees of Renal Function
• Evaluation of Colecalciferol Substitution in Dialysis Patients
• Correction of Anaemia and Progression of Renal Failure on Transplanted Patients
• Prevention Of Nephrotoxicity Following Bone Marrow Transplantation Using Urodilatin and Mannitol
• Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
• Bicarbonate v Saline to Prevent Contrast Nephropathy
• Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
• STAAR-1 Clinical Study
• STAAR-3 Clinical Study
• Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients
• STAAR-2 Clinical Study
• A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.
• A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
• Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
• An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
• Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
• NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization
• Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome
• Effect of Two Iron Preparations on Protein in the Urine
• Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
• Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
• Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC
• Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
• EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
• A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
• Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
• Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography
• Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
• REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
• Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
• Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
• Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
• Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
• Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage
• Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency
• Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
• Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children
• The Effect of CoQ10 Administration on Hemodialysis Patients
• A Study to Evaluate PROCRIT (Epoetin Alfa) for Maintenance Phase Treatment of Patients With Anemia Due to Chronic Kidney Disease (PROMPT)
• Case-Control Study on Analgesics and Nephropathy (SAN)
• SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal Dysfunction
• Forced Diuresis Versus Observation in Resolving Renal Failure After Haemofiltration in Critically Ill Patients
• Efficacy of Intravenous Iron Administration in Hemodialysis Patients
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
• Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
• Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
• Vasodilators and Anti-Oxidant Therapy in Early ATN
• Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration
• Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
• The Effect of Intensive Insulin Therapy in the Surgical Critical Care Unit
• Study Evaluating Sirolimus in the Treatment of Kidney Transplant
• Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
• Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
• Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients
• Benazepril for Advanced Chronic Renal Insufficiency
• Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
• Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients
• Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
• Metabolic Pattern of Cyclosporine A and Acute Renal Failure
• Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
• Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
• A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
• PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography
• Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
• Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
• Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
• Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
• BNP (Nesiritide) vs. Placebo to Protect Kidney Function in Patients Undergoing Heart Bypass Surgery.
• RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography
• Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.
• CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation
• Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery
• Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
• AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
• Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
• Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
• Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
• Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
• Efficacy and Safety Study of GerEPO
• Peginesatide for Anemia in Chronic Hemodialysis Patients
• Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
• Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
• DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
• MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
• Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
• Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients
• Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
• EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)
• Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery
• Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)
• Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Coronary Angiography
• Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography
• Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
• MMF and Calcineurin Inhibitor Withdrawal in CAN
• Iron Sucrose in Stage 3/4 Kidney Disease
• Study Evaluating Sirolimus in Kidney Transplant Recipients in India
• Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
• A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients
• Effect of Cytokines on Growth of Children With Chronic Kidney Failure
• Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
• N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
• A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
• BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
• Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
• Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
• Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure
• Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
• Prevention of Contrast-Induced Nephropathy
• Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
• Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients
• Study Evaluating Sirolimus in Kidney Transplant Recipients.
• Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
• Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
• Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
• Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
• Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
• Olmesartan Medoxomil in Hypertension and Renal Impairment
• Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
• Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
• A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
• An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend
• Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
• The Effect of Isoflurane or Sevoflurane on Kidney Function
• Sodium-Endothelial Function-CKD Study
• Haemodialysis Salt Reduction Study
• Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study
• Effects of Cyclosporine A on Pancreatic Insulin Secretion
• Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)
• PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
• Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
• Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
• Rapamycin Use in Calcineurin Inhibitor (CNI)-Free Immunosuppression for Stabilization/Improvement of Renal Function After Heart Transplantation
• An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery
• Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction
• Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
• The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
• Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
• Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
• An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
• Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
• Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
• A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
• Aggrenox Prevention of Access Stenosis
• Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
• Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
• Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
• Homocysteine Study (HOST)
• Isoflavones and Acute-phase Response in Chronic Renal Failure
• Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
• Kidney Transplant for HIV-Infected Patients in Renal Failure
• Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection
• Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
• Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
• Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)
• A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction